A Community-Based Intervention To Address Health-Related Social Needs For Patients On LAI-PrEP

Brief description of study

The purpose of this study is to evaluate the effect of addressing health-related social needs for people taking long-acting injectable HIV prevention medication (LAI-PrEP). We are particularly interested in recruiting people that are most vulnerable to HIV infection and least likely to be prescribed PrEP, including cisgender women of color and gender diverse persons (transgender or non-binary individuals).

If you are eligible and agree to participate, you would start LAI-PrEP as part of your standard of care and would have 5 research study visits. At the study visits, you would be asked to complete various surveys and 1 interview.

If you decide to participate in this study, you would be asked to come to 5 in-person study visits over a period of approximately 1 year.

You would be compensated for each in-person study visit.


Clinical Study Identifier: s24-00684
ClinicalTrials.gov Identifier: NCT07116629
Principal Investigator: Robert Anwar Pitts.
Other Investigators: Ofole Mgbako, Sahnah Lim.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.